Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
Top Cited Papers
- 6 August 2015
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 16 (9), 1111-1122
- https://doi.org/10.1016/s1470-2045(15)00169-2
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphomaNature Immunology, 2013
- Analysis of FOXO1 mutations in diffuse large B-cell lymphomaBlood, 2013
- Pathogenesis of follicular lymphomaJCI Insight, 2012
- Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)Proceedings of the National Academy of Sciences of the United States of America, 2012
- High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosisLeukemia, 2011
- Predicting the functional impact of protein mutations: application to cancer genomicsNucleic Acids Research, 2011
- Clinical Effect of Point Mutations in Myelodysplastic SyndromesThe New England Journal of Medicine, 2011
- Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylationBlood, 2011
- Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterationsBlood, 2009
- The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survivalBlood, 2008